In order to determine a potential association between the altered IL-6 serum level after BLT and the improvement in depression symptoms, participants were divided into those who responded well, i.e., responders, and those who did not respond well, i.e., non-responders, to BLT. Here, IL6 is linked to depressive symptom measurement.